Literature DB >> 6672021

High-performance thin-layer chromatographic assay for the routine determination of piroxicam in plasma, urine and tissue.

K D Riedel, H Laufen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6672021     DOI： 10.1016/s0378-4347(00)85090-2

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

1.  Analysis of piroxicam in pharmaceutical formulation and human urine by dispersive liquid-liquid microextraction combined with spectrophotometry.

Authors:  Ahad Bavili Tabrizi; Nakisa Seyyedeh Tutunchi
Journal:  Adv Pharm Bull       Date:  2013-02-07

2.  Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase.

Authors:  P Biemond; A J Swaak; J M Penders; C M Beindorff; J F Koster
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

3.  Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism.

Authors:  Chang-Keun Cho; Pureum Kang; Hye-Jung Park; Eunvin Ko; Chou Yen Mu; Yun Jeong Lee; Chang-Ik Choi; Hyung Sik Kim; Choon-Gon Jang; Jung-Woo Bae; Seok-Yong Lee
Journal:  Arch Pharm Res       Date:  2022-05-31       Impact factor: 4.946

4.  Piroxicam in breast milk after long-term treatment.

Authors:  M Ostensen; I Matheson; H Laufen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.